A Critique and Impact Analysis of Decision Modeling Assumptions

Jonathan Karnon, Alan Brennan and Ron Akehurst
Additional contact information
Jonathan Karnon: School of Health and Related Research, University of Sheffield, Sheffield, UK, j.karnon@sheffield.ac.uk
Alan Brennan: School of Health and Related Research, University of Sheffield, Sheffield, UK
Ron Akehurst: School of Health and Related Research, University of Sheffield, Sheffield, UK

Medical Decision Making, 2007, vol. 27, issue 4, 491-499

Abstract: Background . Numerous guidelines have been published defining good practice for the conduct of economic evaluations in general and model-based evaluations in particular. The extent to which guidelines are accepted is unknown, and the impact of deviations from good practice is not generally recorded. The authors identified 4 specific issues in applied studies that may affect the accuracy and comparability of different evaluations. Methods . A descriptive analysis of 4 modeling issues (inclusion of incident cases over a model time horizon, appropriate time horizon, parsimonious model structure, and the handling of age-specific subgroups) is presented. A case study model is analyzed to illustrate the quantitative impact of 3 of the issues. Results . In the case study model, alternative specifications of the modeling framework are shown to alter the estimated cost-effectiveness by large percentages. The combined effect of including incident cases and reduced follow-up yielded the highest divergence from the reference case results, by between 20% and 40%, depending on the age group. Reference case results of an age-weighted population were almost 14% different from the middle single age cohort. Discussion . The identified issues are all generalizable to a wide range of treatment areas and are, or should be, addressed by evaluative guidelines. The authors call for the continued development, dissemination, and application of guidelines for the conduct of economic evaluation in general and model-based economic evaluations in particular.

Keywords: Key words: guidelines; models; decision support; cost-effectiveness; antiplatelet drugs. (Med Decis Making 2007; 27:491—499) (search for similar items in EconPapers)
Date: 2007
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (4)

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/0272989X07300606 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:medema:v:27:y:2007:i:4:p:491-499

DOI: 10.1177/0272989X07300606

Access Statistics for this article

More articles in Medical Decision Making
Bibliographic data for series maintained by SAGE Publications ().